🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Renaissance Technologies (RenTech)’s GRCE Holdings & Trades

First Buy
Q4 2024
Duration Held
8 Quarters
Largest Add
Q3 2026
+186,134 Shares
Current Position
186,134 Shares
$400,188 Value

Renaissance Technologies (RenTech)'s GRCE Position Overview

Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 186,134 shares of Grace Therapeutics, Inc. (GRCE) worth $400,188, representing 0.00% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 8 quarters.

Based on 13F filings, Renaissance Technologies (RenTech) has maintained this position in GRCE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2026, adding 186,134 shares. Largest reduction occurred in Q2 2026, reducing 243,910 shares.

Analysis based on 13F filings available since 2013 Q2

Renaissance Technologies (RenTech)'s Grace Therapeutics (GRCE) Holding Value Over Time

Track share changes against reported price movement

Quarterly Grace Therapeutics (GRCE) Trades by Renaissance Technologies (RenTech)

Report Date Bought/Sold (Sh.) % Change Qtr. End Shares Reported Price
Q3 2026 +186,134 New Buy 186,134 $2.15
Q2 2026 -243,910 Sold Out 0 $0.00
Q1 2026 +114,129 Add 87.94% 243,910 $4.63
Q4 2025 +45,220 Add 53.48% 129,781 $3.46
Q3 2025 +56,936 Add 206.10% 84,561 $2.98
Q2 2025 -14,556 Reduce 34.51% 27,625 $2.97
Q1 2025 -794 Reduce 1.85% 42,181 $2.28
Q4 2024 +42,975 New Buy 42,975 $3.74

Renaissance Technologies (RenTech)'s Grace Therapeutics Investment FAQs

Renaissance Technologies (RenTech) first purchased Grace Therapeutics, Inc. (GRCE) in Q4 2024, acquiring 42,975 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.

Renaissance Technologies (RenTech) has held Grace Therapeutics, Inc. (GRCE) for 8 quarters since Q4 2024.

Renaissance Technologies (RenTech)'s largest addition to Grace Therapeutics, Inc. (GRCE) was in Q3 2026, adding 186,134 shares worth $400,188.

According to the latest 13F filing for Q3 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 186,134 shares of Grace Therapeutics, Inc. (GRCE), valued at approximately $400,188.

As of the Q3 2026 filing, Grace Therapeutics, Inc. (GRCE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.

Renaissance Technologies (RenTech)'s peak holding in Grace Therapeutics, Inc. (GRCE) was 243,910 shares, as reported at the end of Q1 2026.